Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
about
Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high-grade lesions.Clinical and Molecular Spectrum of Liposarcoma.Systemic therapy in retroperitoneal sarcoma management.Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey.Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives.Management of the "Other" retroperitoneal sarcomas.Prognostic models for RPS patients-Attempting to predict patient outcomes.Lessons from three phase III trials assessing neoadjuvant treatment in sarcoma patients.Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts.Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk.Systemic Treatment for Adults with Synovial Sarcoma.Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases.Single metastasis of myxoid liposarcoma from the thigh to thyroid gland: a case report.Regional chemotherapy by isolated limb perfusion prior to surgery compared with surgery and post-operative radiotherapy for primary, locally advanced extremity sarcoma: a comparison of matched cohorts.A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case reportProspective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304
P2860
Q38707594-6DB1D388-3A36-4EBB-91A7-0D91194D72EFQ47315579-843C8D12-F380-440E-AE1C-87281C7722D0Q47384577-586EEB6B-AD6A-4C5D-969F-C31D21B3BC40Q47592150-F6E2E354-3281-4FAA-B1CC-3570AB4A2EE8Q47793357-F50F5A5A-5FF6-4A11-9F46-68C3CAE1EAAEQ48321145-BC6EB0A7-1AEF-4AA0-B7BD-DBD1ED78A496Q48369254-98D17416-7FF3-46C9-B95B-B2C054314588Q49841950-0A913879-DACD-47BD-951F-8B0CB3FE5C3DQ49952075-4B562A62-3056-466A-AC01-4EF006EA4B96Q50105567-DC61819B-B800-4965-A07E-16B56EF352A9Q52357735-F4693E6B-78CA-4781-B5E4-F1141D372276Q52418969-C7D028F2-7E7D-4193-8D30-65E5771B6FFDQ52667763-4E4CB372-CA91-4115-BBD6-F0B8BA28C1B7Q55216228-CE0DC7C7-305E-49ED-B408-6739ED5E7777Q55294287-9B4B3972-05B7-4C80-92E7-B1B99D900B06Q55487470-D55E8767-FB59-415B-A986-F0FFE29B8236Q58720733-12C0EE0A-1594-4CCD-B6AC-BE0047F0B559Q58790735-A71904B1-523A-47C3-B1A8-87DCAB1D1061
P2860
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Histotype-tailored neoadjuvant ...... d, phase 3, multicentre trial.
@ast
Histotype-tailored neoadjuvant ...... d, phase 3, multicentre trial.
@en
type
label
Histotype-tailored neoadjuvant ...... d, phase 3, multicentre trial.
@ast
Histotype-tailored neoadjuvant ...... d, phase 3, multicentre trial.
@en
prefLabel
Histotype-tailored neoadjuvant ...... d, phase 3, multicentre trial.
@ast
Histotype-tailored neoadjuvant ...... d, phase 3, multicentre trial.
@en
P2093
P50
P921
P1433
P1476
Histotype-tailored neoadjuvant ...... d, phase 3, multicentre trial.
@en
P2093
Antonio Lopez Pousa
Carlo Morosi
Elena Palassini
Emanuela Marchesi
Emanuela Palmerini
Giovanni Grignani
Iwona Lugowska
Javier Martin Broto
Jean Michelle Coindre
Oscar Tendero
P304
P356
10.1016/S1470-2045(17)30334-0
P50
P577
2017-05-09T00:00:00Z